Serious and "severe" adverse drug reactions need defining

被引：10

作者：

Frankenfeld, C

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7465期

关键词：

D O I：

10.1136/bmj.329.7465.573

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：573 / 573

页数：1

共 5 条

[1]

Council for International Organizations of Medical Sciences, 1987, INT REP ADV DRUG REA

[2]

*HOFFM LA ROCH US, 2003, LAR MEFL HYDR MED GU

[3] Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: Results from a randomized, double-blind study [J].

Overbosch, D ;

Schilthuis, H ;

Bienzle, U ;

Behrens, RH ;

Kain, KC ;

Clarke, PD ;

Toovey, S ;

Knobloch, J ;

Nothdurft, HD ;

Shaw, D ;

Roskell, NS ;

Chulay, JD .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) :1015-1021

[4] Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study [J].

Schlagenhauf, P ;

Tschopp, A ;

Johnson, R ;

Nothdurft, HD ;

Beck, B ;

Schwartz, E ;

Herold, M ;

Krebs, B ;

Veit, O ;

Allwinn, R ;

Steffen, R .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7423) :1078-+

[5] Preventing malaria in UK travellers - Guidelines stress the need for compliance with prophylaxis and stand by medication [J].

Zuckerman, JN .

BRITISH MEDICAL JOURNAL, 2004, 329 (7461) :305-306

← 1 →